Leqvio
Payments companies reported to CMS as associated with Leqvio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Leqvio, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Leqvio
These are the largest totals companies reported as associated with Leqvio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| R Scott Wright | Rochester, MN | Cardiovascular Disease | $66,074.24 |
| Stephanie Saucier | Hartford, CT | Cardiovascular Disease | $34,774.71 |
| Matthew Budoff | Torrance, CA | Cardiovascular Disease | $29,465.15 |
| Fatima Rodriguez | Stanford, CA | Cardiovascular Disease | $29,244.45 |
| Nihar Desai | New Haven, CT | Cardiovascular Disease | $27,931.26 |
| Pam Taub | La Jolla, CA | Cardiovascular Disease | $26,525.29 |
| Richard Wright | Santa Monica, CA | Advanced Heart Failure and Transplant Cardiology | $23,297.43 |
| Michael Wilkinson | San Diego, CA | Cardiovascular Disease | $21,668.52 |
| Alan Brown | Naperville, IL | Cardiovascular Disease | $20,350.35 |
| Michael Koren | Gainesville, FL | Cardiovascular Disease | $19,402.06 |
Prescribed Leqvio?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.